Literature DB >> 12397042

The effect of caffeine on renal epithelial cells from patients with autosomal dominant polycystic kidney disease.

Franck A Belibi1, Darren P Wallace, Tamio Yamaguchi, Marcy Christensen, Gail Reif, Jared J Grantham.   

Abstract

Autosomal dominant polycystic kidney disease (ADPKD) is a hereditary disorder characterized by the progressive enlargement of cysts derived from tubules. Tubule cell proliferation and chloride-dependent fluid accumulation, mechanisms underlying cyst expansion, are accelerated by adenosine 3':5'-cyclic monophosphate (cAMP). This study examined the extent to which caffeine may stimulate the production of cAMP by cyst epithelial cells, thereby adversely increasing proliferation and fluid secretion. Mural epithelial cells from ADPKD cysts and normal human kidney cortex cells (HKC) were cultured, and cAMP levels were determined in response to caffeine and receptor-mediated agonists linked to adenylyl cyclase. Caffeine, a methylxanthine, slightly increased basal levels of cAMP, as did other nonselective phosphodiesterase (PDE) inhibitors, 1-methyl-3- isobutyl xanthine and theophylline and rolipram, a specific PDE IV inhibitor. More importantly, clinically relevant concentrations of caffeine (10 to 50 micro M) potentiated the effects of desmopressin (DDAVP), prostaglandin E(2) (PGE(2)), and isoproterenol to increase cAMP levels in both ADPKD and HKC cells. By contrast, at concentrations that augmented the DDAVP response, caffeine attenuated cAMP accumulation by adenosine, implicating an action apart from the inhibition of PDE. Caffeine enhanced the effect of DDAVP to stimulate transepithelial short-circuit current of polarized ADPKD monolayers, reflecting an increase in chloride secretion. Caffeine potentiated the effect of DDAVP and PGE(2) to increase the levels of phosphorylated extracellular signal-regulated kinase (P-ERK). By contrast, P-ERK levels in HKC cells were not raised by increased intracellular concentrations of cAMP. It is concluded that PDE inhibition by caffeine increases the accumulation of cAMP, and through this mechanism activates the ERK pathway to cellular proliferation and increases transepithelial fluid secretion in ADPKD cystic epithelium. Caffeine is, therefore, a risk factor for the promotion of cyst enlargement in patients with ADPKD.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12397042     DOI: 10.1097/01.asn.0000025282.48298.7b

Source DB:  PubMed          Journal:  J Am Soc Nephrol        ISSN: 1046-6673            Impact factor:   10.121


  27 in total

Review 1.  Potential pharmacological interventions in polycystic kidney disease.

Authors:  Amirali Masoumi; Berenice Reed-Gitomer; Catherine Kelleher; Robert W Schrier
Journal:  Drugs       Date:  2007       Impact factor: 9.546

Review 2.  Autosomal dominant polycystic kidney disease in children.

Authors:  Melissa A Cadnapaphornchai
Journal:  Curr Opin Pediatr       Date:  2015-04       Impact factor: 2.856

3.  Polycystin-2 and phosphodiesterase 4C are components of a ciliary A-kinase anchoring protein complex that is disrupted in cystic kidney diseases.

Authors:  Yun-Hee Choi; Akira Suzuki; Sachin Hajarnis; Zhendong Ma; Hannah C Chapin; Michael J Caplan; Marco Pontoglio; Stefan Somlo; Peter Igarashi
Journal:  Proc Natl Acad Sci U S A       Date:  2011-06-13       Impact factor: 11.205

Review 4.  Kidney: polycystic kidney disease.

Authors:  Binu M Paul; Gregory B Vanden Heuvel
Journal:  Wiley Interdiscip Rev Dev Biol       Date:  2014-09-03       Impact factor: 5.814

5.  Coffee prevents CCl(4)-induced liver cirrhosis in the rat.

Authors:  Mario G Moreno; Enrique Chávez; Liseth R Aldaba-Muruato; José Segovia; Paula Vergara; Víctor Tsutsumi; Mineko Shibayama; Yadira Rivera-Espinoza; Pablo Muriel
Journal:  Hepatol Int       Date:  2011-01-25       Impact factor: 6.047

Review 6.  Caffeine in Kidney Stone Disease: Risk or Benefit?

Authors:  Paleerath Peerapen; Visith Thongboonkerd
Journal:  Adv Nutr       Date:  2018-07-01       Impact factor: 8.701

7.  Low-Osmolar Diet and Adjusted Water Intake for Vasopressin Reduction in Autosomal Dominant Polycystic Kidney Disease: A Pilot Randomized Controlled Trial.

Authors:  Osama W Amro; Jessica K Paulus; Farzad Noubary; Ronald D Perrone
Journal:  Am J Kidney Dis       Date:  2016-09-20       Impact factor: 8.860

Review 8.  Autosomal dominant polycystic kidney disease and transplantation.

Authors:  Mariusz Niemczyk; Stanisław Niemczyk; Leszek Paczek
Journal:  Ann Transplant       Date:  2009 Oct-Dec       Impact factor: 1.530

9.  Phosphodiesterase Isoform Regulation of Cell Proliferation and Fluid Secretion in Autosomal Dominant Polycystic Kidney Disease.

Authors:  Cibele S Pinto; Archana Raman; Gail A Reif; Brenda S Magenheimer; Corey White; James P Calvet; Darren P Wallace
Journal:  J Am Soc Nephrol       Date:  2015-08-19       Impact factor: 10.121

10.  Aging changes agonist induced contractile responses in permeabilized rat bladder.

Authors:  N Tugba Durlu-Kandilci; Merve Denizalti; Inci Sahin-Erdemli
Journal:  Age (Dordr)       Date:  2015-07-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.